Your browser doesn't support javascript.
loading
Combined photodynamic therapy and transpupillary thermotherapy for small choroidal melanoma.
Rolfe, Olivia J; Stark, Andrew L; Hamilton, Hayley R; D'Mellow, Matthew; Palmer, Jane M; McGrath, Lindsay A; Warrier, Sunil K; Glasson, William J.
Afiliación
  • Rolfe OJ; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia. Electronic address: lily.rolfe@outlook.com.
  • Stark AL; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia.
  • Hamilton HR; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • D'Mellow M; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Palmer JM; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • McGrath LA; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia.
  • Warrier SK; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia.
  • Glasson WJ; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia.
Can J Ophthalmol ; 2024 Feb 29.
Article en En | MEDLINE | ID: mdl-38431268
ABSTRACT

OBJECTIVE:

The objective of this study was to determine whether combining verteporfin-based photodynamic therapy (PDT) and transpupillary thermotherapy (TTT) achieves adequate tumour control while maintaining visual acuity in individuals with small choroidal melanoma of amelanotic, melanotic, and variable pigmentation.

DESIGN:

Individuals with posterior choroidal melanomas up to 3 mm in height underwent verteporfin-based PDT followed by immediate TTT. Further combined laser therapy was performed if a poor response was noted at 12 weeks or beyond. Tumours that demonstrated significant further growth were treated with brachytherapy or enucleation. A total of 37 eyes of 37 patients from the Terrace Eye Centre in Brisbane, Australia were studied. Average age of participants was 59.62 ± 12.45 years, and 17 of 37 participants were female (46%).

METHODS:

This was a retrospective, noncomparative interventional study.

RESULTS:

Seven of the 37 participants (19%) had recurrence of their tumour requiring further brachytherapy or enucleation. There was no statistically significant difference in visual acuity before and after treatment. There were no baseline characteristics that predicted treatment outcome. Ten individuals developed complications including epiretinal membrane (16%), scotoma (8%), cataract (3%), and macular edema (3%). No individuals experienced extraocular extension or progressed to metastatic disease. The mean follow-up time was 49 months.

CONCLUSION:

Combined PDT and TTT achieved 81% tumour control in this study while preserving visual acuity. However, higher rates of local recurrence compared with brachytherapy warrant close follow-up to identify recurrences early.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Can J Ophthalmol Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Can J Ophthalmol Año: 2024 Tipo del documento: Article